Skip to main content

Advertisement

Table 1 Description of active malaria grants, stratified by grant-making organization

From: Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries

  PMI, N = 39, N (%) Global Fund N = 107, N (%) World Bank N = 13, N (%) Total, N = 159, N (%)
WHO Region
 Americas 0 (0) 8 (7.5) 0 (0) 8 (5.0)
 Africa 37 (94.9) 64 11  
 Eastern Mediterranean 0 (0) 1 (0.9) 1 (7.7) 2 (1.3)
 East Asia and Pacific 2 (5.1) 16 (15.0) 1 (7.7) 19 (12.0)
 South Asia 0 (0) 13 (12.2) 0 (0) 13 (8.2)
 Europe 0 (0) 5 (4.7) 0 (0) 5 (3.1)
World Bank income group
 Upper-middle income 4 (10.3) 8 (7.5) 0 (0) 12 (7.6%)
 Lower-middle income 8 (20.5) 45 (42.1) 3 (23.1) 56 (35.2%)
 Low income 27 (69.2) 54 (50.5) 10 (76.9) 91 (57.2%)
Amount of granta 12.7 million USD (3–70 million USD) 30.0 million USD (0.6–284 million USD) 82.0 million USD (46–500 million USD) 33.3 million USD (0.6–500 million USD)
Pharmacovigilance mentions
 Grant mentions pharmacovigilance 21 (53.9) 2 (1.9) 0 (0) 23 (14.5)
 Grant provides budget line for pharmacovigilance 21 (53.9) 16 (15.0) 0 (0) 37 (23.3)
  1. aDenotes a mean and range